In this article, the authors present a novel no-touch saphenous vein harvesting technique with preservation of the perivascular tissue with use of the harvester (MAQUET Getinge Group, Getinge AB, Göteborg, Sweden).
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary Disease
September 21, 2020
September 15, 2020
An open-access large metanalysis on the utility and risks of antiplatelets after PCI. Of note, mortality was not a primary endpoint. The message is that long dual antiplatelet use is an exchange between avoidance of myocardial events and serious bleeding.
The novel oral anticoagulants may enter the arena soon..
May 23, 2020
a readable review that advances the position that
Adolphe Quetelet's formula is now clinically obsolete
May 6, 2020
This article describes recommendations from the North American leadership in regards to the safe reintroduction of cardiovascular services during the COVID-19 pandemic including, but not limited to, ethical considerations, the importance of collaboration amongst public health officials and cardiovascular specialties, and protection of healthcare work
April 13, 2020
Topical review on the epidemic in Britain, with a number of observations that relate to the cardiothoracic surgeons and all healthcare professionals:
-The assertion that the National Health Service in Britain was overrun PRIOR to the pandemic.
-The assertion that acute angina is now being undertreated.
April 3, 2020
In the ISCHEMIA Trial, 5179 patients with moderate or severe myocardial ischemia were randomized equally into two groups based on initial management strategy: initial invasive strategy (angiography and revascularization when feasible) and medical therapy, or initial conservative strategy (medical therapy alone and angiography if medical therapy faile
February 20, 2020
This study of Medicare beneficiaries evaluated how often CABG was performed related to narrow intervals around a patient's birthday.
January 10, 2020
''CABG was significantly better than PCI (p=0·0066........''
December 19, 2019
Following the withdrawal of the support of EACTS for the left main stem chapter of the EACTS/ESC Chapter of the revascularisation guidelines following the BBC Newsnight documentary of this, and the withdrawal of Professor David Taggart as an author of the EXCEL trial published in the NEJM, the EXCEL trial authors have published a very robust defence
November 6, 2019
In this randomized trial, percutaneous coronary intervention and CABG had equivalent outcomes for the composite of death, stroke, or myocardial infarction at five years for patients with left main disease of low or intermediate anatomical complexity.